Sale

Intravenous Solutions Market

Global Intravenous Solutions Market Size, Growth, Analysis: By Type: Partial Parenteral Nutrition, Total Parenteral Nutrition; By Nutrients: Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids; By Bag Type: Large Volume Bags (>250 mL), Others; By Application; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Intravenous Solutions Market Outlook

The growth of the global intravenous solutions market is being driven by the rising prevalence of the chronic diseases across the globe. The market value was 13.03 billion in 2023 and it is anticipated to grow at a CAGR of 7.2% during the forecast period of 2024-2032. The global intravenous solutions market is anticipated to achieve a value of USD 24.26 billion by 2032.

 

Intravenous Solutions Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America, with the bulk of the overall market share, is the dominant market for intravenous solutions. The regional market is being driven by the rapid development of the United States manufacturing capacity owing to a shortage of IV fluids. Moreover, developing countries, including India and China, are increasing their investments in the health sector, which is likely to boost the demand for intravenous solutions. Additionally, manufacturers are implementing new product technologies like offering premixed options for greater convenience and reducing packaging waste.

The development of IV fluids has seen tremendous growth, especially in developed countries. For example, it has been stated that the US Food and Drug Administration (FDA) and other market players are making efforts to alleviate the crisis because of the scarcity of IV saline. In relation to this, Merge, a US-based marketing and development organisation, collaborated with the ground-breaking provider of medical products and services, B. Braun Medical, to launch omnichannel campaign 'Solutions for Life' in May 2020. This programme seeks to ensure an effective supply of IV solutions, approved by the United States FDA.

 

Intravenous Solutions Market by Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Intravenous (IV) solutions refer to a complete mixture of vital nutrients intended to refill fluid losses, treat electrolyte imbalances as well as maintain fluid balance in intravenous therapy. It also provides the patients suffering from diabetes, cancer, and other diseases with the necessary nutrients. Intravenous solutions can contain water incorporated in concentrations with electrolytes, sugar, or medicines, as prescribed by the patient. In accordance with this, these solutions differ in rate and quantity, relying on the patient's medical condition, age, as well as body size.

Based on type, the market can be divided into the following:

  • Partial Parenteral Nutrition
  • Total Parenteral Nutrition

On the basis of nutrients, the industry can be segmented as follows:

  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids

The regional markets for intravenous solutions include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Intravenous Solutions Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Owing to unhealthy dietary habits, there has been a rise in disease prevalence, including gastrointestinal disorder, neurological disorders, cancer, and diabetes, which is the main factor contributing to the development of the intravenous solutions market. In fact, since these options are available in compact packets, it is safer for patients to use the drips at the convenience of their home rather than hospitals. In addition, developing countries, including India and China, are increasing their investment in the health sector that is likely to boost the demand for intravenous solutions. Additionally, manufacturers are implementing new product technologies like offering premixed options for greater convenience and reducing packaging waste.

 

Competitive Landscape 

The report gives a detailed analysis of the following companies in the global intravenous solutions market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Ajinomoto Health & Nutrition North America, Inc. 
  • B. Braun Medical Inc.
  • ICU Medical, Inc.
  • Baxter International, Inc. 
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Nutrients
  • Bag Type
  • Application
  • End User
  • Region
Breakup by Type
  • Partial Parenteral Nutrition
  • Total Parenteral Nutrition
Breakup by Nutrients
  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids
Breakup by Bag Type
  • Large Volume Bags (>250 mL)
  • Small Volume Bags (<250 mL)
Breakup by Application
  • Basic IV Solution
  • Nutritional IV Solution
  • Blood IV Solution
  • Drug IV Solution
  • Irrigation IV Solution
Breakup by End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Homecare Settings
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
  • Industry Events, Initiatives, and Trends
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Ajinomoto Health & Nutrition North America, Inc.
  • B. Braun Medical Inc.
  • ICU Medical, Inc.
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Pfizer inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Healthcare
  • Grifols, S.A.
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Intravenous Solutions Market Overview 

    3.1    Global Intravenous Solutions Market Historical Value (2017-2023) 
    3.2    Global Intravenous Solutions Market Forecast Value (2024-2032)
4    Global Intravenous Solutions Market Landscape
    4.1    Global Intravenous Solutions Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Intravenous Solutions Product Landscape
        4.2.1    Analysis by Type 
        4.2.2    Analysis by Nutrients
        4.2.3    Analysis by Bag Type
        4.2.4    Analysis by Applications
        4.2.5    Analysis by End User
5    Global Intravenous Solutions Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Intravenous Solutions Market Segmentation 
    6.1    Global Intravenous Solutions Market by Type
        6.1.1    Market Overview
        6.1.2    Partial Parenteral Nutrition
        6.1.3    Total Parenteral Nutrition
    6.2    Global Intravenous Solutions Market by Nutrients
        6.2.1    Market Overview
        6.2.2    Carbohydrates
        6.2.3    Salts and Electrolytes
        6.2.4    Minerals
        6.2.5    Vitamins
        6.2.6    Amino Acids
    6.3    Global Intravenous Solutions Market by Bag Type
        6.3.1    Market Overview
        6.3.2    Large Volume Bags (>250 mL)
        6.3.3    Small Volume Bags (<250 mL)
    6.4    Global Intravenous Solutions Market by Application
        6.4.1    Market Overview
        6.4.2    Basic IV Solution
        6.4.3    Nutritional IV Solution
        6.4.4    Blood IV Solution
        6.4.5    Drug IV Solution
        6.4.6    Irrigation IV Solution
    6.5    Global Intravenous Solutions Market by End User
        6.5.1    Market Overview
        6.5.2    Hospitals
        6.5.3    Clinics
        6.5.4    Ambulatory Surgical Centres
        6.5.5    Homecare Settings
        6.5.6    Others
    6.6    Global Intravenous Solutions Market by Region
        6.6.1    Market Overview
        6.6.2    North America 
        6.6.3    Europe
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Intravenous Solutions Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Intravenous Solutions Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Intravenous Solutions Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Intravenous Solutions Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Intravenous Solutions Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication Year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Ajinomoto Health & Nutrition North America, Inc.
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    B. Braun Medical Inc.
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    ICU Medical, Inc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Baxter International, Inc.
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Fresenius Kabi AG
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Pfizer inc.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Otsuka Pharmaceutical Co., Ltd.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Vifor Pharma Management Ltd.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    JW Life Science
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Amanta Healthcare
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Grifols, S.A.
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
18    Global Intravenous Solutions Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global intravenous solutions market attained a value of nearly USD 13.03 billion.

The market is projected to grow at a CAGR of 7.2% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 24.26 billion by 2032.

The major drivers of the industry, such as unhealthy dietary habits, disease prevalence, including gastrointestinal disorder, neurological disorders, cancer and diabetes, and increasing investments in the health sector, are expected to aid the market growth.

The key market trends guiding the growth of the intravenous solutions market include the launch of new product technologies that offer premixed options for greater convenience and reducing packaging waste.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share.

The major types of intravenous solutions in the industry are partial parenteral nutrition and total parenteral nutrition.

The leading nutrients of intravenous solutions are carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids.

The major players in the industry are Ajinomoto Health & Nutrition North America, Inc., B. Braun Medical Inc., ICU Medical, Inc., and Baxter International, Inc., among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER